Myocarditis as the first manifestation of eosinophilic granulomatosis with polyangiitis

被引:1
|
作者
Radojkovic, Danijela Djordjevic [1 ,2 ]
Apostolovic, Svetlana [1 ,2 ]
Damjanovic, Miodrag [1 ]
Kostic, Tomislav [1 ,2 ]
Levakov, Aleksandra Fejsa [3 ,4 ]
Dimitrijevic, Marko [5 ]
Tomasevic, Ruzica Jankovic [1 ]
Dakic, Sonja [1 ,2 ]
Bozinovic, Nenad [1 ,2 ]
Pavicevic, Milena [1 ]
机构
[1] Univ Clin Ctr Nis, Cardiol Clin, Blvd Dr Zoran Dindica 48, Nish 18108, Serbia
[2] Univ Nis, Fac Med, Nish, Serbia
[3] Univ Novi Sad, Fac Med, Novi Sad, Serbia
[4] Univ Clin Ctr Vojvodina, Novi Sad, Serbia
[5] Gen Hosp Zajecar, Zajecar, Serbia
关键词
diagnosis; histological techniques; myocarditis; eosinophilia; churg-strauss syndrome; CHURG-STRAUSS-SYNDROME; CARDIOLOGY WORKING GROUP; CARDIAC INVOLVEMENT; POSITION STATEMENT; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; CLASSIFICATION; MANAGEMENT; DIAGNOSIS; PREVALENCE;
D O I
10.2298/VSP230218026D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Myocarditis is not a rare diagnosis, but its etiology often remains unknown as it requires extensive diagnostic work. Eosinophilic granulomatosis with polyangiitis (EGPA) or Churg -Strauss syndrome is a very rare systemic disease that is not easy to diagnose. Myocarditis in EGPA is uncommon and usually occurs in the late stages of the disease. Case report. A 22 -year -old man was admitted with acute coronary syndrome. Using coronary angiography, the presence of stenoses on the epicardial coronary arteries was ruled out, and a working diagnosis of myocardial infarction with non -obstructive coronary arteries (MINOCA) was established. Then, we found inflammatory syndrome, eosinophilia, and a lot of systemic symptoms and signs. The diagnostic work included extensive laboratory tests, which ruled out infectious agents. Then, immunological tests, a computed tomography scan of the chest, cardiac magnetic resonance imaging (MRI) and a biopsy of the bone marrow, nasal mucosa, and skin were performed. We managed to establish the diagnosis of myopericarditis by cardiac MRI . The cause of myocarditis - EGPA, was found only after the histopathological finding of the skin biopsy, which enabled adequate immunosuppressive therapy. Conclusion. The accurate diagnosis was crucial for the correct, causal treatment of the patient, especially because he needed life -long immunosuppressive therapy. In order for such complex patients to receive adequate treatment, a multidisciplinary approach and perseverance in the diagnostic evaluation of the etiology of myocarditis are necessary .
引用
收藏
页码:942 / 948
页数:7
相关论文
共 50 条
  • [41] Update on eosinophilic granulomatosis with polyangiitis
    Furuta, Shunsuke
    Iwamoto, Taro
    Nakajima, Hiroshi
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (04) : 430 - 436
  • [42] Rituximab for eosinophilic granulomatosis with polyangiitis
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E19 - E19
  • [43] Benralizumab in Eosinophilic Granulomatosis with Polyangiitis
    Cottu, Adrien
    Groh, Matthieu
    Desaintjean, Charlene
    Marchand-Adam, Sylvain
    Guillevin, Loic
    Puechal, Xavier
    Lazaro, Estibaliz
    Samson, Maxime
    Taille, Camille
    Durel, Cecile-Audrey
    Diot, Elisabeth
    Nicolas, Sarah
    Guilleminault, Laurent
    Ebbo, Mikael
    Cathebras, Pascal
    Dupin, Clairelyne
    Yildiz, Halil
    Belfeki, Nabil
    Pugnet, Gregory
    Chauvin, Pierre
    Jouneau, Stephane
    Lifermann, Francois
    Martellosio, Jean-Philippe
    Cottin, Vincent
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1351 - 1354
  • [45] Prevasculitic Eosinophilic Granulomatosis With Polyangiitis
    Burtson, Kathryn M.
    Bishop, Jonathan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [46] Biologics for eosinophilic granulomatosis with polyangiitis
    Caminati, Marco
    Maule, Matteo
    Bello, Federica
    Emmi, Giacomo
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (01) : 36 - 43
  • [47] Mepolizumab for eosinophilic granulomatosis with polyangiitis
    Loïc Guillevin
    Nature Reviews Rheumatology, 2017, 13 : 518 - 519
  • [48] EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS : NOT FOR THE LIGHTHEARTED
    Gopalarathinam, Rajesh
    Indramohan, Pavithra
    Vishwanathan, Swathi
    Madhanakumar, Aarthi
    Sharma, Tarun
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S617 - S618
  • [49] Benralizumab in eosinophilic granulomatosis with polyangiitis
    Laorden, Daniel
    Romero, David
    Dominguez-Ortega, Javier
    MEDICINA CLINICA, 2022, 158 (10): : 441 - +
  • [50] Benralizumab in eosinophilic granulomatosis with polyangiitis
    Laorden, Daniel
    Romero, David
    Dominguez-Ortega, Javier
    MEDICINA CLINICA, 2022, 158 (09): : 441 - 442